Debt-to-equity of Sarepta Therapeutics, Inc. from 30 Sep 2013 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Sarepta Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2013 to 31 Dec 2025.
  • Sarepta Therapeutics, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 182%, a 7.6% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Sarepta Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 182% -15% -7.6% 31 Dec 2025
Q3 2025 173% -55% -24% 30 Sep 2025
Q2 2025 180% -75% -30% 30 Jun 2025
Q1 2025 191% -92% -32% 31 Mar 2025
Q4 2024 197% -111% -36% 31 Dec 2024
Q3 2024 228% -149% -40% 30 Sep 2024
Q2 2024 256% -194% -43% 30 Jun 2024
Q1 2024 283% -165% -37% 31 Mar 2024
Q4 2023 308% -106% -26% 31 Dec 2023
Q3 2023 377% +57% +18% 30 Sep 2023
Q2 2023 449% +151% +51% 30 Jun 2023
Q1 2023 447% +123% +38% 31 Mar 2023
Q4 2022 414% +46% +12% 31 Dec 2022
Q3 2022 320% -76% -19% 30 Sep 2022
Q2 2022 298% -24% -7.5% 30 Jun 2022
Q1 2022 324% +71% +28% 31 Mar 2022
Q4 2021 369% +167% +83% 31 Dec 2021
Q3 2021 396% +228% +136% 30 Sep 2021
Q2 2021 322% +188% +141% 30 Jun 2021
Q1 2021 253% +151% +147% 31 Mar 2021
Q4 2020 202% +132% +189% 31 Dec 2020
Q3 2020 168% +110% +191% 30 Sep 2020
Q2 2020 134% +75% +128% 30 Jun 2020
Q1 2020 103% +40% +65% 31 Mar 2020
Q4 2019 70% -0.83% -1.2% 31 Dec 2019
Q3 2019 58% -16% -21% 30 Sep 2019
Q2 2019 59% +1.5% +2.6% 30 Jun 2019
Q1 2019 62% +16% +35% 31 Mar 2019
Q4 2018 71% +37% +109% 31 Dec 2018
Q3 2018 73% +55% +292% 30 Sep 2018
Q2 2018 57% +36% +177% 30 Jun 2018
Q1 2018 46% +21% +80% 31 Mar 2018
Q4 2017 34% +1.7% +5.4% 31 Dec 2017
Q3 2017 19% -18% -49% 30 Sep 2017
Q2 2017 21% -32% -61% 30 Jun 2017
Q1 2017 26% -21% -45% 31 Mar 2017
Q4 2016 32% -5.1% -14% 31 Dec 2016
Q3 2016 37% +7.7% +26% 30 Sep 2016
Q2 2016 53% +32% +151% 30 Jun 2016
Q1 2016 46% +31% +200% 31 Mar 2016
Q4 2015 37% +22% +141% 31 Dec 2015
Q3 2015 29% +14% +94% 30 Sep 2015
Q2 2015 21% +2.8% +15% 30 Jun 2015
Q1 2015 15% -15% -48% 31 Mar 2015
Q4 2014 15% -30% -66% 31 Dec 2014
Q3 2014 15% -47% -76% 30 Sep 2014
Q2 2014 18% 30 Jun 2014
Q1 2014 30% 31 Mar 2014
Q4 2013 45% 31 Dec 2013
Q3 2013 62% 30 Sep 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.